Becker's Healthcare February 6, 2025
Alexandra Murphy

As pharmaceutical companies push back against the 340B Drug Pricing Program, several states, including Utah, Colorado, Arkansas, Maine and Nebraska, are introducing legislation to protect the program and ensure continued access to discounted medications for safety-net hospitals and clinics.

The bills aim to address pharmaceutical restrictions and provide transparency, ensuring that hospitals can continue supporting low-income patients and funding critical services.

Here are seven notes:

  1. The 340B drug pricing program mandates drug manufacturers to provide discounted medications to safety-net hospitals and clinics serving low-income communities.
  2. Multiple states, including Utah, Colorado, Arkansas, Maine and Nebraska, have introduced bills to safeguard the 340B program, amid increasing restrictions from pharmaceutical companies.
  3. Utah’s bill, spearheaded by Rep. Steve...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Health System / Hospital, Pharma, Pharma / Biotech, Provider, States
Per capita spending on health care: 13 states at the bottom
California's regulatory roadblocks: The policies limiting ASC expansion
The market dynamics shaping the state with the most ASCs
Health care spending per person: 12 states where it is highest — a slideshow
California reintroduces healthcare private equity legislation

Share This Article